A new era of risk prediction for patients with high-risk melanoma.

Olofsson Bagge, Roger; Hieken, Tina J

Olofsson Bagge, Roger; Hieken, Tina J.

Affiliation

Olofsson Bagge R; Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy and Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: rob@gu.se.
Hieken TJ; Department of Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.

Lancet Oncol ; 25(4): 415-416, 2024 Apr.

Article in En | MEDLINE | ID: mdl-38547888

Subject(s)

Melanoma; Skin Neoplasms; Humans; Melanoma/genetics; Skin Neoplasms/genetics; Risk Assessment; Patients

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Journal: Lancet Oncol / Lancet oncol / Lancet oncology Journal subject: NEOPLASIAS Year: 2024 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google